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S U M M A R Y
Maternal alcohol use during pregnancy exposes both premature and term newborns to the toxicity of
alcohol and its metabolites. Foetal alcohol exposure adversely effects the lung. In contrast to the adult
‘‘alcoholic lung’’ phenotype, an inability to identify the newborn exposed to alcohol in utero has limited
our understanding of its effect on adverse pulmonary outcomes. This paper will review advances in
biomarker development of in utero alcohol exposure. We will highlight the current understanding of in
utero alcohol’s toxicity to the developing lung and immune defense. Finally, we will present recent
clinical evidence describing foetal alcohol’s association with adverse pulmonary outcomes including
bronchopulmonary dysplasia, viral infections such as respiratory syncytial virus and allergic asthma/
atopy. With research to deﬁne alcohol’s effect on the lung and translational studies accurately identifying
the exposed offspring, the full extent of alcohol’s effects on clinical respiratory outcomes of the newborn
or child can be determined.
 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
EDUCATIONAL AIMS
 To stress the continued, yet often unrecognized incidence of foetal alcohol exposure in both premature and term newborns.
 To review the advances in biomarker(s) development to assist in the accurate identiﬁcation of the alcohol exposed premature and
term newborn.
 To explore the current understanding of the pathophysiological effects of alcohol exposure on the developing lung.
 To review the latest data evaluating the association between in utero alcohol exposure and clinical respiratory outcomes of the
newborn and child including bronchopulmonary dysplasia, viral infection and allergic asthma.
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Despite the continued advances in studies focusing on the
recognition of alcohol related birth defects (ARBD) including foetal
alcohol spectrum disorders (FASD) [1], there remains a limited
acknowledgment of the fact that in utero alcohol adversely effects
multiple organs in the developing newborn, including the
developing lung. This paper will highlight and update the current
ﬁeld of study into foetal alcohol’s effect on the developing lung
since our last review [2]. Our adult colleagues have made
signiﬁcant advances in deciphering the pathophysiology underly-
ing the adverse effects of alcohol exposure on multiple cell types
within the lung. Indeed, respiratory complications such as acute* Corresponding author. Tel.: +404 727 3360; fax: +404 727 3236.
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4.0/).lung injury, adult respiratory distress syndrome (ARDS) and
pneumonia are now well recognized sequelae of the ‘‘alcoholic
lung phenotype [3,4].’’ Due to impaired immune defenses of
multiple cell types including alveolar macrophage, neutrophils and
lymphocytes, adults with alcohol use disorders are more likely to
develop serious pulmonary infections including bacterial and viral
pneumonia [5]. Despite advances in understanding the adult
immunocompromised ‘‘alcoholic lung [6],’’ there remains much to
be learned to fully understand the complex consequences of in
utero alcohol exposure during development on the lung.
We will review the continued prevalence of foetal alcohol
exposure to premature and term newborns in our society and
highlight the recent advances in the identiﬁcation of this exposure
during pregnancy using a variety of chemical biomarkers in various
matrices. We will discuss recent advances in our understanding of
the cellular injury speciﬁc to the developing lung exposed to
alcohol in utero. Foetal alcohol’s effect on immune defenses,
particularly as they relate to the lung will be reviewed. We willo alcohol effects on foetal, neonatal and childhood lung disease.
8.006
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
T.W. Gauthier, L.A.S. Brown / Paediatric Respiratory Reviews xxx (2016) xxx–xxx2
G Model
YPRRV-1159; No. of Pages 4summarize recent clinical updates evaluating foetal alcohol’s effect
on clinical respiratory outcomes, including bronchopulmonary
dysplasia/death in the very low birthweight (VLBW) newborn, viral
infection such as respiratory syncytial virus (RSV), and allergic
asthma in neonates and children. Finally, we will highlight
important areas for future investigations to identify and improve
pulmonary outcomes of alcohol-exposed newborns and children.
CONTINUED EXPOSURE OF NEWBORNS, BOTH TERM AND
PRETERM, TO ALCOHOL IN UTERO
Despite persistent recommendations from healthcare workers
and authorities such as the US Surgeon General, alcohol use during
pregnancy in continues to place the developing fetus at risk for a
variety of adverse birth outcomes. The National Birth Defects
Prevention Study reported that 30% of women drank during their
pregnancy while 8.3% binge drank (> 5 drinks/sitting) [7]. A recent
report again noted that 30% of all pregnancies were complicated by
maternal report of alcohol exposure [8]. Educational campaigns
have clariﬁed that there is no known ‘‘safe’’ level of alcohol
consumption during pregnancy. Unfortunately, despite these
efforts, the prevalence of alcohol consumption among pregnant
women remains alarmingly high and was even higher among those
with a college degree compared to those with less education [9].
Although some reports fail to demonstrate a link between low to
moderate drinking and the risk of premature delivery, others note
an increased risk of preterm delivery with maternal alcohol use
during pregnancy [10,11]. Multiple studies demonstrate that heavy
or binge alcohol consumption increase the risk of premature
delivery 2-3 fold, particularly in those less than 32 weeks gestation
[12–15]. Therefore, some authors propose that extreme prematuri-
ty should be considered an alcohol-related birth defect [14]. Lester
et al reported that 30% of the mothers reported alcohol use during
pregnancy in a very low birthweight (VLBW) newborn population
[16]. Similarly, in a recent study of mothers who delivered VLBW
(<1500 grams at birth) newborns admitted to the Neonatal
Intensive Care Unit, we recently demonstrated that one third of
the mothers admitted to alcohol use during pregnancy [17].
It is important to recognize that maternal report of alcohol
consumption during pregnancy inherently results in an under-
representation of the true prevalence of alcohol use during
pregnancy [18–20]. It is likely, therefore, that in utero alcohol
exposure occurs in both premature and term newborns, and has
the potential to adversely affect multiple developing organs.
Although maternal drinking during pregnancy has been noted to
decrease from the ﬁrst trimester compared to the third trimester of
pregnancy, organogenesis of multiple organ systems, particularly
the lung and the developing immune system, remains vulnerable
to the exposure to alcohol.
ADVANCES IN THE IDENTIFICATION OF THE ALCOHOL EXPOSED
NEWBORN
In an effort to eliminate the underreporting of alcohol exposure
during pregnancy and bypass the need for maternal self-report,
much research continues to focus on the development of accurate
and clinically useful biomarkers of fetal alcohol exposure. Without
accurate identiﬁcation of the exposed newborn, either born
prematurely or at term, advances in our understanding of the
adverse effects of alcohol in organ systems such as the lung remain
limited. Unlike adults with alcohol use disorders, typical laboratory
biomarkers may not be optimal for identifying foetal alcohol
exposure. Blood alcohol or direct oxidative metabolites such as
acetaldehyde levels may not address long term intermittent foetal
exposure in utero. Furthermore, routine blood tests such as gamma-
glutamyl transferase, mean corpuscular volume, hemoglobinPlease cite this article in press as: Gauthier TW, Brown LAS. In uter
Paediatr. Respir. Rev. (2016), http://dx.doi.org/10.1016/j.prrv.2016.0associated acetaldehyde, and carbohydrate deﬁcient transferrin
are not optimal during pregnancy [21].
Thus, more sensitive biomarkers of non-oxidative alcohol
metabolism have been investigated to more accurately identify
the alcohol-exposed newborn. Non-oxidative metabolites of
alcohol can be detected for prolonged periods in various matrices
such as meconium, hair, ﬁngernails, umbilical cord tissue,
placenta, and newborn blood. Fatty acid ethyl esters (FAEEs) in
meconium have been the most extensively investigated biomark-
ers of in utero alcohol exposure and their elevation can predict
cognitive deﬁcits in the exposed newborn [22]. The investigation
and validation of other non-oxidative metabolites of alcohol such
as ethyl glucuronide (EtG), ethyl sulfate (EtS), phosphatidylethanol
(PEth), or their combination remain the focus of extensive research
[23–26]. Indeed, PEth has been demonstrated as a valid and stable
biomarker of previous alcohol exposure and can be detected on dry
blood spot samples [27].
While the literature has largely remained focused on develop-
ing biomarkers to identify foetal alcohol exposure to term
newborns, there remains a paucity of data regarding the
identiﬁcation of alcohol exposure in premature newborns. We
recently reported that the placenta, a non-invasive and easily
obtainable tissue source, demonstrated elevated FAEEs in VLBW
exposed to alcohol in utero [17]. Additionally, we also found that
the FAEE ethyl linolenate was signiﬁcantly elevated in the
meconium of alcohol-exposed VLBW premature newborns [28]. Fi-
nally, in a guinea pig model of foetal ethanol exposure, we
demonstrated accumulation of FAEEs in the lung tissue of the
newborn guinea pigs exposed to ethanol in utero [29]. Whether
additional matrices, such as amniotic ﬂuid, lung (tracheal aspirate)
ﬂuid or meconium can be sources for biomarker(s) to accurately
identify alcohol exposure in the understudied premature popula-
tion requires further investigations.
Thus, continued evaluations using translational studies of
premature and term newborns as well as animal models of foetal
alcohol exposure are necessary to determine the validity of a
biomarker panel. The goal of such studies would ultimately be to
develop a sensitive and reliable panel of biomarker(s) that could be
utilized in the clinical arena. Accurately determining both the
amount of alcohol exposure and the time of gestational develop-
ment during exposure in both term and premature newborns
would allow advancement in our understanding of its potential
adverse consequences to the developing lung.
ALCOHOL-INDUCED CELLULAR INJURY TO THE DEVELOPING
LUNG
Foetal alcohol exposure increases lipid peroxidation products,
lipid peroxidation adduct formation on proteins, and DNA oxidation
in multiple organs [2]. Speciﬁcally for the developing lung, research
continues to demonstrate alcohol-induced cellular injury in multiple
animal models, suggesting that alcohol exposure alters lung
development. In mice, acute alcohol administered mid-gestation
increased histone acetylation in the developing lung resulting in
apoptosis of both mesenchymal and epithelial cells [30]. Further-
more, early administration of alcohol to pregnant mice caused
signiﬁcant DNA damage in the foetal mouse lung [31]. Reductions in
surfactant protein-B (SP-B) and altered surfactant phospholipid
composition have been reported in multiple models including rat
[32] and sheep [33,34], suggesting direct effects on the epithelial
cells of the developing lung. Finally, in these models, increased
collagen type III alpha1 gene [32] and increased collagen deposition
[34] were also demonstrated in exposed pup lungs, suggesting
ﬁbroblast alterations with alcohol exposure. These data, taken
together, suggest that in utero alcohol exposure alters multiple cell
types in the developing lung and could potentially increase the risko alcohol effects on foetal, neonatal and childhood lung disease.
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increased collagen in the alcohol-exposed lung raises the possibility
that foetal alcohol exposure could result in altered pulmonary
dynamics and increase the risk of lung scarring lesions such as
bronchopulmonary dysplasia in the exposed offspring.
IN UTERO ALCOHOL AND ALTERED IMMUNE DEFENSES
Multiple animal models suggest that in utero alcohol exposure
deranges the immune defense in the developing lung [35]. In sheep
models, foetal alcohol exposure resulted in reduction of the
collectins SP-A [33,34] and SP-D [36] and alters baseline pro-
inﬂammatory cytokine mRNA expression in the exposed neonatal
lung [33,37]. We have demonstrated in multiple animal models
that in utero alcohol suppresses the maturation and function of the
resident alveolar macrophage (AM), increasing the risk of bacterial
infection [38]. This altered AM immune defense is modulated by
alcohol-induced mitochondrial oxidant stress and mitochondrial
dysfunction [39,40]. Given that FAEEs are a reliable biomarker of
alcohol exposure and accumulate in the neonatal lung after foetal
alcohol exposure [29], we recently evaluated the direct effects of
these compounds on the neonatal AM. We hypothesized that
FAEEs would impair mitochondrial functioning and in-part
contribute to AM dysfunction observed with alcohol exposure.
Indeed, we demonstrated that FAEEs such as ethyl oleate directly
injure the neonatal AM, causing mitochondrial oxidative stress,
apoptosis and cellular dysfunction [29]. Direct effects of FAEE on
other cell types within the developing lung remain unexplored.
Whether AM dysfunction and the risk of bacterial infection
persists beyond the neonatal period in the foetal alcohol exposed
lung is unknown. Previous studies have demonstrated that after
foetal alcohol exposure, adult animals continued to demonstrate
impaired adaptive immunity [41], and an increased risk and
severity of pulmonary inﬂuenza infection [42]. Former premature
newborns and infants are at increased risk for viral infections,
particularly respiratory syncytial virus (RSV). Investigators evalu-
ating the pathogenesis of RSV using a lamb model suggest that
foetal alcohol exposure may further increase neonatal susceptibil-
ity to this viral infection [43].
FOETAL ALCOHOL EXPOSURE AND RISK OF ADVERSE
PULMONARY OUTCOMES
We have noted recent advances in deﬁning in utero alcohol’s
effect on multiple cell types within the developing lung using
multiple experimental animal models. However, unlike our adult
colleagues [4–6], clinical studies deﬁning foetal alcohol-induced
pulmonary effects in newborns and children remain limited. As
previously noted, scientiﬁc progress in this regard remains limited,
in part due to the inability to accurately identify the alcohol-
exposed newborn or child. We have previously demonstrated that
maternal alcohol exposure during pregnancy was associated with
an increased risk of infection in both term [44] and premature
newborns [45]. In a recent study, we evaluated VLBW premature
newborns admitted to the Neonatal Intensive Care Unit and
identiﬁed in utero alcohol exposure via maternal self-report after
delivery. In this cohort (n=143), maternal alcohol use was
associated with an increased odds of BPD/Death in the premature
newborn [46]. Furthermore, similar to our earlier work in term
newborns [44], heavy maternal drinking (7 drinks/week) was
associated with increased odds of developing late onset sepsis
(LOS) in the VLBW [46]. Although the sample size evaluated was
small, the data strongly suggest that additional clinical investiga-
tions with larger numbers are warranted to evaluate alcohol’s
association with adverse pulmonary outcomes such as BPD or
associated LOS in the VLBW newborn.Please cite this article in press as: Gauthier TW, Brown LAS. In uter
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exposure and risk of infection, including pulmonary viral infection,
researchers in Argentina recently evaluated whether maternal
alcohol consumption during pregnancy increased the risk of life
threatening respiratory infections in children < 2 years of age.
Alcohol exposure during pregnancy was determined via maternal
self-report at the time of the child’s hospitalization. In this study,
alcohol consumption was associated with an increased risk of life
threatening respiratory infections (particularly RSV infection) in
boys [47]. Such clinical reports and animal data [43] emphasize
and justify the need for continued investigations evaluating
whether in utero alcohol exposure increases the risk of respiratory
viral infections such as RSV in the exposed infant or child.
Although it has long been demonstrated that in utero alcohol
exposure increases cord blood IgE [48], investigations continue to
assess whether foetal alcohol exposure alters the risk of atopy and/
or asthma in the exposed child. In a recent report evaluating a
Japanese cohort, maternal alcohol intake during pregnancy signiﬁ-
cantly increased the risk of atopic eczema before age 3 and before
age 5 [49]. These data are in agreement with other authors, who
demonstrated an increased risk of atopic dermatitis in early infancy
[50] and during the ﬁrst 7 years of life in alcohol-exposed offspring
[51]. Nevertheless, the data on foetal alcohol’s effect on the
development of asthma is less convincing. In the Japanese cohort,
offspring exposed to maternal alcohol demonstrated a 2 fold, albeit
non-signiﬁcant (p=0.058) increased risk of asthma before age 3,
suggesting further studies are warranted [49]. However, in a large
Norwegian cohort, maternal alcohol use during pregnancy had no
signiﬁcant effect on asthma at age 3 or age 7 [52], while a study of
newborns in Copenhagen demonstrated no effects of alcohol
exposure on infant lung function testing at one month of age [53].
CONCLUSIONS
In summary, despite continued foetal alcohol exposure to both
term and premature newborns, the clinical awareness of such
exposure and our clinical ability to accurately identify the exposed
newborn remains lacking. Continued advances in biomarker
development using animal models and translational investigations
hold the key to accurate identiﬁcation of the alcohol-exposed
newborn born either prematurely or at term gestation. By
ascertaining alcohol’s effect on multiple cell types within the
developing lung and accurately identifying the exposed offspring,
the full extent of alcohol’s effects on clinical respiratory outcomes,
including bronchopulmonary dysplasia and infectious pulmonary
complications of the newborn or child will be determined. Although
signiﬁcant progress has been made in understanding the effects of
chronic alcohol on the adult ‘‘alcoholic lung,’’ further research into
the ‘‘developing alcoholic lung’’ is required since exposure (amount
and timing) is superimposed on development. As such, we cannot
assume the alterations demonstrated in the adult alcoholic lung will
be evident in newborns exposed in utero or in children after such in
utero exposure. Additionally, further investigations are needed to
increase our understanding of the effects of alcohol’s metabolites
such as FAEE on cell injury in multiple developing organs including
the lung [22]. Finally, determining whether therapeutic approaches
currently under investigation in adults exposed to alcohol, such as
antioxidant replacement or zinc replacement therapy [54] could
also be applicable and beneﬁt the exposed newborn lung requires
full investigation.
DIRECTIONS FOR FUTURE RESEARCH
 The continued development of accurate biomarker panels for the
identiﬁcation of both premature and term newborns exposed to
alcohol in utero.o alcohol effects on foetal, neonatal and childhood lung disease.
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alcohol and its metabolites on multiple cell types of the
developing lung.
 Translational studies to further deﬁne the associations between
in utero alcohol exposure and neonatal and childhood lung
diseases.
 Evaluate potential therapeutic interventions for the alcohol-
exposed newborn at risk for adverse pulmonary outcomes.
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